OTCMKTS:CMIIU CM Life Sciences II (CMIIU) Stock Price, News & Analysis $11.22 -0.64 (-5.40%) As of 09/1/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CM Life Sciences II Stock (OTCMKTS:CMIIU) Get CM Life Sciences II alerts:Sign Up Key Stats Today's Range$11.06▼$11.8550-Day Range$11.22▼$11.2252-Week Range$10.02▼$15.89Volume33,700 shsAverage Volume193,992 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CM Life Sciences II, Inc. is a special purpose acquisition company (SPAC) incorporated in Delaware in February 2021. The company’s units trade on the OTC market under the ticker CMIIU. As a blank‐check company, CM Life Sciences II seeks to identify and acquire one or more businesses in the life sciences industry, including biotechnology, biopharmaceuticals, medical devices and related areas. The company raised capital through its initial public offering in mid-2021, issuing public units each comprising one share of Class A common stock and a fraction of a warrant. Proceeds from the offering are held in a trust account until CM Life Sciences II completes a business combination. If no qualifying transaction is completed by the SPAC’s deadline, funds are returned to public stockholders. CM Life Sciences II is sponsored by Casdin Capital, a Manhattan-based investment firm focused exclusively on life sciences equity and venture investing. Casdin Capital brings a team of experienced industry professionals and scientific advisors to the SPAC’s search process, leveraging deep sector expertise to evaluate potential targets in domestic and international markets.AI Generated. May Contain Errors. Read More Receive CMIIU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CM Life Sciences II and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMIIU Stock News HeadlinesForbion raises over $2.2 billion for two new life science fundsOctober 16, 2024 | bizjournals.comPharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulationOctober 10, 2024 | markets.businessinsider.comREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.October 16 at 2:00 AM | Paradigm Press (Ad)Revolutionising organoid manufacturing: Monmouth Scientific Class 2 Biological Safety Cabinets enhance sterility and efficiency at Molecular Devices' new Life Science facility.August 14, 2024 | msn.comFAMU: Today, Tomorrow, and Forever | Gallop Franklin IIJuly 22, 2024 | msn.comNew £900m life science campus approvedAugust 21, 2023 | bbc.comBHere's what to expect from CM Life Sciences II A's earningsMarch 27, 2023 | markets.businessinsider.comSolving problems involving height and lengthDecember 1, 2022 | bbc.co.ukSee More Headlines CMIIU Stock Analysis - Frequently Asked Questions How have CMIIU shares performed this year? CM Life Sciences II's stock was trading at $11.22 at the beginning of 2025. Since then, CMIIU shares have increased by 0.0% and is now trading at $11.22. How do I buy shares of CM Life Sciences II? Shares of CMIIU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Services – Research, Development, Testing Labs Sub-IndustryBusiness Services Current SymbolOTCMKTS:CMIIU CIKN/A Webii.cmlifesciencesspac.com Phone(303) 625-9000FaxN/AEmployees320Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:CMIIU) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CM Life Sciences II Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CM Life Sciences II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.